A former Guernsey resident, who was jailed for selling unlicensed cancer drugs, faces having £1.4 million of assets confiscated.

David Noakes, who used to own Guernsey-based company Immuno Biotech, was arrested last month in Cornwall following a European Arrest warrant. He had spent five months on the run after failing to report to police on bail in December.

The 67-year-old will now lose his aircraft, boat, Aston Martin, Rolls Royce and UK and Guernsey bank accounts.

This outcome follows a four-year investigation by the Medicines and Healthcare products Regulatory Agency (MHRA).

Noakes served a 15-month prison sentence from November 2018 after pleading guilty to four charges relating to the manufacture, sale and supply of an unlicensed medicine (GcMAF), and one count of money laundering.

Globulin component Macrophage Activating Factor (GcMAF) was a product made from human blood. Noakes advertised is as a ‘miracle cure’ for a range of conditions including cancer, HIV and autism, with no scientific basis to support these medicinal claims.

The court heard Noakes made over £13 million from the sale of GcMAF between 2011 and 2015.

GcMAF was sold through various European websites which UK buyers would have had no difficulty accessing. Production was stopped in January 2015, as a result of the MHRA’s investigation, and a seizure of more than 10,000 vials took place, which Noakes could have sold for £5.5 million.

The £1,349,400.48 confiscation order means that the identified assets will be realised and paid to the Home Office for distribution under the Proceeds of Crime Act (POCA) 2002 incentivisation scheme.

Our investigation team has worked relentlessly to bring David Noakes and his associates to justice and today’s decision to deny him the proceeds of his criminality is welcome. Noakes put public health at risk through the unlicensed manufacturing and sale of GcMAF products, which were not fit for human consumption or for use as medicines.

Andy Morling, MHRA Head of Enforcement